Yixuan Cen

Hangzhou, 310006, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

Proteomic profiling and molecular reclassification of high-grade serous ovarian cancer identifies prognostic subtypes and immunotherapy biomarkers.

Proteomic profiling and molecular reclassification of high-grade serous ovarian cancer identifies prognostic subtypes and immunotherapy biomarkers.

Journal: EBioMedicine

Published: May 04, 2025

Simultaneously delivery of functional gallium ions and hydrogen sulfide to endow potentiated treatment efficacy in chemo- and PARPi-resistant ovarian cancer.

Simultaneously delivery of functional gallium ions and hydrogen sulfide to endow potentiated treatment efficacy in chemo- and PARPi-resistant ovarian cancer.

Journal: Journal of nanobiotechnology

Published: November 29, 2024

A novel non-invasive mRNA-lncRNA biomarker panel for accurate prediction of cervical squamous cell carcinoma and adenocarcinoma.

A novel non-invasive mRNA-lncRNA biomarker panel for accurate prediction of cervical squamous cell carcinoma and adenocarcinoma.

Journal: Journal of gynecologic oncology

Published: October 09, 2024

Correction: Long non-coding RNA SLC25A21-AS1 inhibits the development of epithelial ovarian cancer by specifically inducing PTBP3 degradation.

Correction: Long non-coding RNA SLC25A21-AS1 inhibits the development of epithelial ovarian cancer by specifically inducing PTBP3 degradation.

Journal: Biomarker research

Published: September 28, 2024

The biomarker potential of circPOLD1 and its binding protein YBX1 in cervical carcinogenesis.

The biomarker potential of circPOLD1 and its binding protein YBX1 in cervical carcinogenesis.

Journal: Journal of translational medicine

Published: September 15, 2024

Nanoengineered Gallium Ion Incorporated Formulation for Safe and Efficient Reversal of PARP Inhibition and Platinum Resistance in Ovarian Cancer.

Nanoengineered Gallium Ion Incorporated Formulation for Safe and Efficient Reversal of PARP Inhibition and Platinum Resistance in Ovarian Cancer.

Journal: Research (Washington, D.C.)

Published: December 01, 2022

Long non-coding RNA SLC25A21-AS1 inhibits the development of epithelial ovarian cancer by specifically inducing PTBP3 degradation.

Long non-coding RNA SLC25A21-AS1 inhibits the development of epithelial ovarian cancer by specifically inducing PTBP3 degradation.

Journal: Biomarker research

Published: August 25, 2022

Breaking the Iron Homeostasis: A "Trojan Horse" Self-Assembled Nanodrug Sensitizes Homologous Recombination Proficient Ovarian Cancer Cells to PARP Inhibition.

Breaking the Iron Homeostasis: A "Trojan Horse" Self-Assembled Nanodrug Sensitizes Homologous Recombination Proficient Ovarian Cancer Cells to PARP Inhibition.

Journal: ACS nano

Published: August 03, 2022

The impact of neoadjuvant chemotherapy on the tumor microenvironment in advanced high-grade serous carcinoma.

The impact of neoadjuvant chemotherapy on the tumor microenvironment in advanced high-grade serous carcinoma.

Journal: Oncogenesis

Published: April 25, 2022

Oncogenic circTICRR suppresses autophagy via binding to HuR protein and stabilizing GLUD1 mRNA in cervical cancer.

Oncogenic circTICRR suppresses autophagy via binding to HuR protein and stabilizing GLUD1 mRNA in cervical cancer.

Journal: Cell death & disease

Published: March 16, 2022

Single-Cell RNA Sequencing Reveals the Tissue Architecture in Human High-Grade Serous Ovarian Cancer.

Single-Cell RNA Sequencing Reveals the Tissue Architecture in Human High-Grade Serous Ovarian Cancer.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: January 28, 2022

Global characterization of extrachromosomal circular DNAs in advanced high grade serous ovarian cancer.

Global characterization of extrachromosomal circular DNAs in advanced high grade serous ovarian cancer.

Journal: Cell death & disease

Published: September 06, 2021

Showing 1-12 of 14

Last Updated: 09/26/2026